MVM Life Science Partners: A global venture capital firm investing in healthcare and pharmaceutical sectors.
Location
London, Greater London, GB
Founded
2005
MVM Partners is a global venture capital firm specializing in healthcare investments. With teams in Boston and London, the firm focuses on medical technology, pharmaceuticals, diagnostics, contract research and manufacturing, digital health, and other healthcare sectors. MVM typically invests in Series B to Series E rounds, with a broad investment outlook spanning various stages of company growth.
The firm's portfolio includes notable companies such as Cara Therapeutics, GT Medical Technologies, and Vero Biotech. MVM partners with management teams to bring innovative products to market, drive growth, and make strategic acquisitions. With over $1 billion in assets under management and extensive experience in healthcare investing, MVM offers valuable expertise and support to its portfolio companies.
MVM Partners - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages